IndiaMart
FIEO
Full Product Description:
Tirzepatide 40 mg Injection represents the highest strength formulation in the Tirzepatide therapeutic range, offering maximum efficacy for patients with advanced Type 2 Diabetes Mellitus (T2DM) and obesity. Developed for global distribution by BLUEPILL EXPRESS, a leading merchant exporter, this dual-action injectable is designed for exceptional glycemic control and clinically proven weight management results. Manufactured under WHO-GMP and ISO-certified facilities located in India and China, Tirzepatide 40 mg Injection is available for international merchant export, third-party manufacturing, and private-label production as per market demand.
Mechanism of Action:
Tirzepatide functions as a dual agonist of both Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. This dual incretin mechanism enhances insulin secretion, suppresses glucagon release, and delays gastric emptying. These combined effects reduce blood glucose levels, promote fat metabolism, and induce significant weight loss. The synergy between GIP and GLP-1 receptor activation offers superior metabolic control, improved insulin sensitivity, and sustainable cardiovascular benefits.
Key Features and Benefits:
High-dose 40 mg formulation designed for enhanced therapeutic effect in advanced diabetes management. Dual receptor activation for powerful glucose regulation and body fat reduction. Once-weekly subcutaneous injection for convenience and improved patient adherence. Demonstrated reduction in HbA1c and body weight in clinical studies. Manufactured in WHO-GMP and ISO-certified facilities in India and China. Suitable for private labeling, contract manufacturing, and bulk export under global compliance standards. Available with full regulatory documentation and cold-chain logistics support.
Therapeutic Indications:
Management of Type 2 Diabetes Mellitus in adults inadequately controlled on lower doses or other oral antidiabetic agents. Chronic weight management in obese and overweight adults. Improvement of insulin resistance and lipid metabolism. Reduction of cardiometabolic risk and protection of pancreatic beta-cell function.
Dosage and Administration:
Tirzepatide 40 mg Injection is administered once weekly by subcutaneous route in the abdomen, thigh, or upper arm. It is generally initiated at 2.5 mg weekly and titrated every 4 weeks by 2.5 mg increments until the maintenance dose of 40 mg is achieved based on clinical response and tolerance. Injections should be performed under medical guidance, with the same day and time schedule each week. Do not exceed the recommended weekly dose.
Pharmacological Classification:
Therapeutic Category: Antidiabetic / Metabolic Modulator. Drug Class: Dual GIP and GLP-1 Receptor Agonist. ATC Code: A10BJ06.
Precautions and Warnings:
Not suitable for patients with Type 1 Diabetes Mellitus or diabetic ketoacidosis. Contraindicated in individuals with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Caution advised in patients with renal or hepatic impairment, gastrointestinal disorders, or a history of pancreatitis. Common side effects include nausea, diarrhea, vomiting, appetite loss, and fatigue. Serious adverse reactions are rare but may include pancreatitis, severe hypoglycemia (when used with insulin or sulfonylureas), and allergic responses. Not recommended during pregnancy or lactation unless specifically prescribed by a physician.
Storage and Handling:
Store Tirzepatide 40 mg Injection in a refrigerator between 2°C to 8°C (36°F to 46°F). Do not freeze or expose to direct sunlight. Maintain cold-chain integrity during shipping and handling. Keep the product out of reach of children.
Manufacturing and Quality Compliance:
BLUEPILL EXPRESS ensures that Tirzepatide 40 mg Injection is manufactured in WHO-GMP and ISO-compliant facilities located in both India and China. Each production unit adheres to strict international quality benchmarks with validated sterile production environments. All batches undergo rigorous testing for assay, sterility, particulate matter, pH, and stability to ensure consistent product performance. Quality assurance processes meet pharmacopoeial standards such as IP, BP, and USP.
Export and Documentation Support:
BLUEPILL EXPRESS provides comprehensive export support including Certificate of Analysis, Certificate of Origin, Batch Manufacturing Record, Stability Data, MSDS, Commercial Invoice, Packing List, and Cold-Chain Compliance Certificate. Assistance with product registration, labeling customization, and dossier documentation is available for importers in regulated and semi-regulated markets.
Why Choose BLUEPILL EXPRESS:
BLUEPILL EXPRESS is a globally recognized merchant exporter offering dual-country manufacturing flexibility from India and China to meet client requirements. The company ensures WHO-GMP, ISO, and international regulatory compliance in all formulations. It offers end-to-end export solutions, including private labeling, custom branding, and regulatory documentation. With extensive distribution networks across Asia, Africa, Europe, the Middle East, and Latin America, BLUEPILL EXPRESS guarantees reliable logistics, temperature-controlled transport, and consistent product supply.
Clinical Efficacy and Global Recognition:
Tirzepatide 40 mg Injection provides one of the highest available doses in its class, achieving up to 2.8% reduction in HbA1c and 18–22% mean body weight loss as demonstrated in global clinical trials. It enhances insulin sensitivity, improves lipid profiles, and reduces cardiovascular risk markers, positioning it as a premium choice for long-term diabetes and weight management programs.
Global Supply Capabilities:
BLUEPILL EXPRESS exports Tirzepatide 40 mg Injection with full regulatory, technical, and logistical support for bulk, hospital, and government tenders. The product is supplied under strict cold-chain conditions with multi-language labeling and customized packaging options. Both air and sea shipment modes are available with end-to-end temperature tracking and documentation assistance.
Conclusion:
Tirzepatide 40 mg Injection is a next-generation dual GIP and GLP-1 receptor agonist that delivers unmatched benefits in blood glucose management and weight reduction for Type 2 Diabetes and obesity. With world-class manufacturing in India and China and international merchant export by BLUEPILL EXPRESS, clients are assured of top-tier quality, efficacy, and compliance. BLUEPILL EXPRESS continues to serve as a trusted global pharmaceutical partner, offering innovative formulations and reliable supply chains that support healthcare systems worldwide.
